Clinical Trial
Accepted on 28 Nov 2024
Very low doses of rituximab in autoimmune hemolytic anemia-an open-label, phase II pilot trial
in Hematology
Clinical Trial
Accepted on 28 Nov 2024
in Hematology
Review
Accepted on 28 Nov 2024
in Genome Editing in Human Health and Disease
Original Research
Accepted on 28 Nov 2024
in Health Economics
Case Report
Accepted on 28 Nov 2024
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 28 Nov 2024
in Pulmonary Medicine
Editorial
Accepted on 28 Nov 2024
in Microbial Symbioses
Editorial
Accepted on 28 Nov 2024
in Medical Physics and Imaging
Review
Accepted on 28 Nov 2024
in Cancer Immunity and Immunotherapy
Brief Research Report
Accepted on 28 Nov 2024
in Interventions in Aging
Original Research
Accepted on 28 Nov 2024
in Striated Muscle Physiology
Editorial
Accepted on 28 Nov 2024
in Drug, Venom & Anaphylaxis
Review
Accepted on 28 Nov 2024
in Vascular Physiology
Mini Review
Accepted on 28 Nov 2024
Original Research
Accepted on 28 Nov 2024
in General Cardiovascular Medicine
Original Research
Accepted on 28 Nov 2024
in Respiratory Physiology and Pathophysiology
Original Research
Accepted on 28 Nov 2024
in Alloimmunity and Transplantation